Financials Owens & Minor, Inc.

Equities

OMI

US6907321029

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:03 2024-05-16 pm EDT			5-day change	1st Jan Change
19.12 ^USD	-5.39%		+4.03%	-0.78%

May. 09	Transcript : Owens & Minor, Inc. - Shareholder/Analyst Call
May. 06	Baird Adjusts Owens & Minor Price Target to $24 From $28, Maintains Neutral Rating	MT

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	324.9	1,989	3,282	1,489	1,474	1,462	-	-
Enterprise Value (EV) ¹	1,766	2,891	4,174	3,902	3,122	3,207	2,965	2,691
P/E ratio	-5.02 x	57.6 x	14.8 x	67.3 x	-35.7 x	273 x	22.6 x	14.7 x
Yield	0.19%	0.04%	0.02%	-	-	0.02%	0.02%	0.03%
Capitalization / Revenue	0.04 x	0.23 x	0.34 x	0.15 x	0.14 x	0.14 x	0.13 x	0.13 x
EV / Revenue	0.19 x	0.34 x	0.43 x	0.39 x	0.3 x	0.3 x	0.27 x	0.24 x
EV / EBITDA	7.83 x	8.63 x	8.48 x	7.54 x	5.94 x	5.63 x	4.73 x	3.96 x
EV / FCF	15.5 x	10.3 x	56 x	24.6 x	5.86 x	45.5 x	11.1 x	8.78 x
FCF Yield	6.45%	9.68%	1.78%	4.06%	17.1%	2.2%	8.97%	11.4%
Price to Book	0.68 x	2.41 x	3.5 x	1.57 x	1.58 x	1.51 x	1.31 x	1.12 x
Nbr of stocks (in thousands)	62,852	73,512	75,456	76,234	76,501	76,499	-	-
Reference price ²	5.170	27.05	43.50	19.53	19.27	19.11	19.11	19.11
Announcement Date	3/4/20	2/24/21	2/23/22	2/28/23	2/20/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	9,211	8,480	9,785	9,955	10,334	10,662	10,960	11,309
EBITDA ¹	225.7	335.2	492.3	517.8	525.8	569.2	627.2	679.2
EBIT ¹	153	283.4	442.4	369.1	304.7	326.7	369.2	406
Operating Margin	1.66%	3.34%	4.52%	3.71%	2.95%	3.06%	3.37%	3.59%
Earnings before Tax (EBT) ¹	-28.72	109.9	276.8	10.89	-54.73	-1.446	120	225.9
Net income ¹	-62.37	29.87	221.6	22.39	-41.3	0.8	88.4	131.4
Net margin	-0.68%	0.35%	2.26%	0.22%	-0.4%	0.01%	0.81%	1.16%
EPS ²	-1.030	0.4700	2.940	0.2900	-0.5400	0.0700	0.8467	1.300
Free Cash Flow ¹	113.9	280	74.49	158.4	532.8	70.5	266	306.5
FCF margin	1.24%	3.3%	0.76%	1.59%	5.16%	0.66%	2.43%	2.71%
FCF Conversion (EBITDA)	50.44%	83.54%	15.13%	30.59%	101.34%	12.39%	42.41%	45.13%
FCF Conversion (Net income)	-	937.46%	33.61%	707.6%	-	8,812.5%	300.9%	233.26%
Dividend per Share ²	0.0100	0.0100	0.0100	-	-	0.004000	0.004000	0.005000
Announcement Date	3/4/20	2/24/21	2/23/22	2/28/23	2/20/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2
Net sales ¹	2,467	2,407	2,500	2,497	2,551	2,523	2,563	2,592	2,656	2,613	2,642	2,670	2,737	2,664	2,700
EBITDA ¹	97.38	118.5	155.6	127	116.7	108.7	112.8	134.7	169.6	116.3	134.4	145.6	167.2	128.1	149.7
EBIT ¹	84.86	104.9	113.6	83.45	67.16	47.67	62	84.24	110.8	57.36	75.89	86.97	108.3	67	86.96
Operating Margin	3.44%	4.36%	4.54%	3.34%	2.63%	1.89%	2.42%	3.25%	4.17%	2.2%	2.87%	3.26%	3.96%	2.51%	3.22%
Earnings before Tax (EBT) ¹	-	-	-	-	-	-	-	-	21	-27.11	-5.444	4.612	26.5	-	-
Net income ¹	41.98	39.28	28.6	12.5	-57.99	-24.42	-28.24	-6.426	17.78	-21.89	-2.2	5.3	19.6	2.9	18.5
Net margin	1.7%	1.63%	1.14%	0.5%	-2.27%	-0.97%	-1.1%	-0.25%	0.67%	-0.84%	-0.08%	0.2%	0.72%	0.11%	0.69%
EPS ²	0.5500	0.5200	0.3700	0.1600	-0.7700	-0.3200	-0.3700	-0.0800	0.2300	-0.2900	-0.0300	0.0833	0.2767	0.0400	0.2300
Dividend per Share ²	0.002500	0.002500	0.002500	0.002500	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	2/23/22	5/3/22	8/3/22	11/2/22	2/28/23	5/5/23	8/4/23	11/3/23	2/20/24	5/3/24	-	-	-	-	-

¹USD in Million²USD

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	1,441	903	892	2,414	1,648	1,745	1,503	1,229
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	6.386 x	2.694 x	1.812 x	4.661 x	3.134 x	3.065 x	2.397 x	1.809 x
Free Cash Flow ¹	114	280	74.5	158	533	70.5	266	307
ROE (net income / shareholders' equity)	6.93%	24.5%	26.9%	19.5%	11.3%	12.9%	15.1%	15.9%
ROA (Net income/ Total Assets)	0.92%	4.12%	6.45%	4.13%	2.01%	4.37%	5.01%	5.53%
Assets ¹	-6,803	725.6	3,436	542.4	-2,051	18.32	1,766	2,376
Book Value Per Share ²	7.630	11.20	12.40	12.40	12.20	12.70	14.60	17.10
Cash Flow per Share ²	2.740	5.340	1.650	4.260	9.770	2.690	5.770	5.750
Capex ¹	42.4	59.2	49.7	167	208	229	218	225
Capex / Sales	0.46%	0.7%	0.51%	1.67%	2.01%	2.15%	1.99%	1.99%
Announcement Date	3/4/20	2/24/21	2/23/22	2/28/23	2/20/24	-	-	-

¹USD in Million²USD

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Owens & Minor, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

19.11 USD

Average target price

22.57 USD

Spread / Average Target

+18.11%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment Wholesale

	1st Jan change	Capi.
OWENS & MINOR, INC.	-0.78%	1.55B
HENRY SCHEIN, INC.	-1.82%	9.57B
SHIP HEALTHCARE HOLDINGS, INC.	-0.58%	1.48B
AS ONE CORPORATION	-10.73%	1.15B
GKHT MEDICAL TECHNOLOGY CO., LTD.	-17.18%	869M
TOKAI CORP.	-1.05%	474M
EXCELSIOR MEDICAL CO., LTD.	+2.26%	440M
GAUSH MEDITECH LTD	-46.69%	379M
COWEALTH MEDICAL CHINA CO.,LTD.	-21.74%	344M
WIN-PARTNERS CO., LTD.	-3.01%	215M

Medical Equipment Wholesale